Handelsbanken Fonder
VIR icon

Handelsbanken Fonder’s Vir Biotechnology VIR Stock Holding History

Handelsbanken Fonder’s Portfolio VIR Stock Details VIR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-26,400
Closed -$198K – 1574
2024
Q3 		$198K Hold
26,400
– – ﹤0.01% 1495
2024
Q2 		$235K Buy
26,400
+3,900
+17% +$37.4K ﹤0.01% 1456
2024
Q1 		$228K Hold
22,500
– – ﹤0.01% 1478
2023
Q4 		$226K Buy
22,500
+9,300
+70% +$85K ﹤0.01% 1488
2023
Q3 		$124K Hold
13,200
– – ﹤0.01% 1529
2023
Q2 		$324K Buy
13,200
+100
+0.8% +$2.51K ﹤0.01% 1309
2023
Q1 		$305K Buy
+13,100
New +$335K ﹤0.01% 1282
2022
Q4 		– Sell
-11,000
Closed -$212K – 1614
2022
Q3 		$212K Hold
11,000
– – ﹤0.01% 1416
2022
Q2 		$280K Sell
11,000
-800
-7% -$18.7K ﹤0.01% 1365
2022
Q1 		$303K Buy
11,800
+600
+5% +$17.8K ﹤0.01% 1513
2021
Q4 		$469K Buy
11,200
+1,600
+17% +$62.7K ﹤0.01% 1394
2021
Q3 		$418K Hold
9,600
– – ﹤0.01% 1453
2021
Q2 		$454K Sell
9,600
-2,700
-22% -$123K ﹤0.01% 1448
2021
Q1 		$631K Hold
12,300
– – ﹤0.01% 1069
2020
Q4 		$329K Hold
12,300
– – ﹤0.01% 1361
2020
Q3 		$422K Buy
+12,300
New +$530K ﹤0.01% 1078

Other funds holding VIR

SIAU
SB Investment Advisers (UK) London, United Kingdom $7.73B AUM 2.35% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Handelsbanken Fonder's VIR Position: Q4 2024 in Review

Handelsbanken Fonder sold out of Vir Biotechnology (VIR) in Q4 2024, closing a stake of 26,400 shares — an estimated $198K sold.

Handelsbanken Fonder first reported a position in VIR in Q3 2020 and held it in 16 quarters. The position peaked at $631K in Q1 2021. 208 funds tracked by Wall St. Rank hold VIR as of Q4 2024.

  • Handelsbanken Fonder reported no remaining Vir Biotechnology position as of Q4 2024 after selling out during the quarter.
  • Handelsbanken Fonder sold 26,400 Vir Biotechnology shares in Q4 2024, an estimated $198K.
  • Handelsbanken Fonder first reported a position in Vir Biotechnology in Q3 2020 and held it in 16 quarters.
  • Handelsbanken Fonder's Vir Biotechnology position peaked at $631K in Q1 2021.
  • 208 funds tracked by Wall St. Rank held Vir Biotechnology as of Q4 2024.

Based on Handelsbanken Fonder's 13F filing for Q4 2024, filed 3 Feb 2025.